Download PDF
Semin Respir Crit Care Med 2018; 39(02): 227-254
DOI: 10.1055/s-0037-1617443
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fungal Infections Complicating Lung Transplantation

Nina M. Clark
1   Division of Infectious Diseases, Department of Medicine, Loyola University Medical Center, Maywood, Illinois
,
S. Samuel Weigt
2   Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California
,
Michael C. Fishbein
3   Department of Pathology and Laboratory Medicine, The David Geffen School of Medicine at UCL, Los Angeles, California
,
Bernard Kubak
4   Division of Infectious Diseases, Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California
,
John A. Belperio
2   Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California
,
Joseph P. Lynch III
2   Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
26 March 2018 (online)

    Permissions and Reprints

Abstract

Lung transplantation is an increasingly utilized modality for treating advanced lung disease. However, lung transplant recipients (LTRs) experience high rates of infection-related mortality and, compared with other solid organ transplant recipients, are at increased risk of infectious complications given the intensity of immunosuppression employed, the presence of airway abnormalities after surgery and exposure of the allograft to the environment. Fungal infections, particularly mold infections, are problematic after transplantation as they are often associated with limited treatment options and poor outcomes. We describe the non-Candida fungal infections occurring in LTRs, including their epidemiology, clinical features, and treatment.

Keywords

invasive fungal infections - mold - organ transplant - lung transplant - aspergillosis - mucormycosis - fusariosis - scedosporiosis - triazoles
 

  • References

  • 1 Valapour M, Skeans MA, Smith JM. , et al. OPTN/SRTR 2015 annual data report: lung. Am J Transplant 2017; 17 (Suppl. 01) 357-424
    CrossrefPubMedGoogle Scholar
  • 2 Pappas PG, Alexander BD, Andes DR. , et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50 (08) 1101-1111
    CrossrefPubMedGoogle Scholar
  • 3 Kauffman CA, Freifeld AG, Andes DR. , et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis 2014; 16 (02) 213-224
    CrossrefPubMedGoogle Scholar
  • 4 Gavaldà J, Meije Y, Fortún J. , et al; ESCMID Study Group for Infections in Compromised Hosts. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 2014; 20 (Suppl. 07) 27-48
    PubMedGoogle Scholar
  • 5 Vazquez R, Vazquez-Guillamet MC, Suarez J, Mooney J, Montoya JG, Dhillon GS. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience. Transpl Infect Dis 2015; 17 (02) 259-266
    CrossrefPubMedGoogle Scholar
  • 6 Doligalski CT, Benedict K, Cleveland AA. , et al. Epidemiology of invasive mold infections in lung transplant recipients. Am J Transplant 2014; 14 (06) 1328-1333
    CrossrefPubMedGoogle Scholar
  • 7 Peghin M, Monforte V, Martin-Gomez MT. , et al. 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation. Transpl Int 2016; 29 (01) 51-62
    CrossrefPubMedGoogle Scholar
  • 8 Park BJ, Pappas PG, Wannemuehler KA. , et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006. Emerg Infect Dis 2011; 17 (10) 1855-1864
    CrossrefPubMedGoogle Scholar
  • 9 Neofytos D, Treadway S, Ostrander D. , et al. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Transpl Infect Dis 2013; 15 (03) 233-242
    CrossrefPubMedGoogle Scholar
  • 10 Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis 2007; 9 (04) 310-317
    CrossrefPubMedGoogle Scholar
  • 11 Cuellar-Rodriguez J, Avery RK, Lard M. , et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49 (05) 710-716
    CrossrefPubMedGoogle Scholar
  • 12 Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?. Clin Microbiol Infect 2009; 15 (Suppl. 05) 93-97
    PubMedGoogle Scholar
  • 13 Abidi MZ, Sohail MR, Cummins N. , et al. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies. Mycoses 2014; 57 (11) 687-698
    CrossrefPubMedGoogle Scholar
  • 14 Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34 (07) 909-917
    CrossrefPubMedGoogle Scholar
  • 15 Riches ML, Trifilio S, Chen M. , et al. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant 2016; 51 (02) 277-282
    CrossrefPubMedGoogle Scholar
  • 16 Cornely OA, Maertens J, Winston DJ. , et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356 (04) 348-359
    CrossrefPubMedGoogle Scholar
  • 17 Ullmann AJ, Lipton JH, Vesole DH. , et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356 (04) 335-347
    CrossrefPubMedGoogle Scholar
  • 18 Wang JF, Xue Y, Zhu XB, Fan H. Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs. Eur J Clin Microbiol Infect Dis 2015; 34 (04) 651-659
    CrossrefPubMedGoogle Scholar
  • 19 Perfect JR, Hachem R, Wingard JR. Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients. Clin Infect Dis 2014; 59 (Suppl. 05) S352-S355
    CrossrefPubMedGoogle Scholar
  • 20 Segal BH. Aspergillosis. N Engl J Med 2009; 360 (18) 1870-1884
    CrossrefPubMedGoogle Scholar
  • 21 Gregg KS, Kauffman CA. Invasive aspergillosis: epidemiology, clinical aspects, and treatment. Semin Respir Crit Care Med 2015; 36 (05) 662-672
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 47 (08) 1041-1050
    CrossrefPubMedGoogle Scholar
  • 23 Morgan J, Wannemuehler KA, Marr KA. , et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43 (Suppl. 01) S49-S58
    CrossrefPubMedGoogle Scholar
  • 24 Cahill BC, Hibbs JR, Savik K. , et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112 (05) 1160-1164
    CrossrefPubMedGoogle Scholar
  • 25 Weigt SS, Elashoff RM, Huang C. , et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009; 9 (08) 1903-1911
    CrossrefPubMedGoogle Scholar
  • 26 Husain S, Sole A, Alexander BD. , et al. The 2015 International Society for Heart and Lung Transplantation guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary. J Heart Lung Transplant 2016; 35 (03) 261-282
    CrossrefPubMedGoogle Scholar
  • 27 Bodey G, Bueltmann B, Duguid W. , et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11 (02) 99-109
    CrossrefPubMedGoogle Scholar
  • 28 Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26 (04) 781-803 , quiz 804–805
    CrossrefPubMedGoogle Scholar
  • 29 Mühlemann K, Wenger C, Zenhäusern R, Täuber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia 2005; 19 (04) 545-550
    CrossrefPubMedGoogle Scholar
  • 30 Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100 (13) 4358-4366
    CrossrefPubMedGoogle Scholar
  • 31 Singh N. Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management. Med Mycol 2005; 43 (Suppl. 01) S267-S270
    CrossrefPubMedGoogle Scholar
  • 32 Skiada A, Pagano L, Groll A. , et al; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17 (12) 1859-1867
    CrossrefPubMedGoogle Scholar
  • 33 Siwek GT, Dodgson KJ, de Magalhaes-Silverman M. , et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39 (04) 584-587
    CrossrefPubMedGoogle Scholar
  • 34 Lanternier F, Sun HY, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis 2012; 54 (11) 1629-1636
    PubMedGoogle Scholar
  • 35 Perkhofer S, Lass-Flörl C, Hell M. , et al. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents 2010; 36 (06) 531-536
    CrossrefPubMedGoogle Scholar
  • 36 Singh N, Husain S. ; AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation. Am J Transplant 2013; 13 (Suppl. 04) 228-241
    CrossrefPubMedGoogle Scholar
  • 37 Minari A, Husni R, Avery RK. , et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002; 4 (04) 195-200
    CrossrefPubMedGoogle Scholar
  • 38 Lee JH, Hyun JS, Kang DY, Lee HJ, Park SG. Rare complication of bronchoesophageal fistula due to pulmonary mucormycosis after induction chemotherapy for acute myeloid leukemia: a case report. J Med Case Reports 2016; 10: 195
    CrossrefPubMedGoogle Scholar
  • 39 Safar A, Marsan J, Marglani O, Al-Sebeih K, Al-Harbi J, Valvoda M. Early identification of rhinocerebral mucormycosis. J Otolaryngol 2005; 34 (03) 166-171
    CrossrefPubMedGoogle Scholar
  • 40 Singh N, Aguado JM, Bonatti H. , et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis 2009; 200 (06) 1002-1011
    CrossrefPubMedGoogle Scholar
  • 41 Chitasombat MN, Kontoyiannis DP. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Curr Opin Infect Dis 2016; 29 (04) 340-345
    CrossrefPubMedGoogle Scholar
  • 42 Davari HR, Malekhossini SA, Salahi HA. , et al. Outcome of mucormycosis in liver transplantation: four cases and a review of literature. Exp Clin Transplant 2003; 1 (02) 147-152
    PubMedGoogle Scholar
  • 43 Husain S, Silveira FP, Azie N, Franks B, Horn D. Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance® registry analysis. Med Mycol 2017; 55 (03) 269-277
    PubMedGoogle Scholar
  • 44 Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006; 6 (10) 2365-2374
    CrossrefPubMedGoogle Scholar
  • 45 Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 2009; 22 (03) 447-465
    CrossrefPubMedGoogle Scholar
  • 46 Lewis RE, Kontoyiannis DP. Invasive aspergillosis in glucocorticoid-treated patients. Med Mycol 2009; 47 (Suppl. 01) S271-S281
    CrossrefPubMedGoogle Scholar
  • 47 Patterson TF. Risk stratification for invasive aspergillosis: early assessment of host susceptibility. Med Mycol 2009; 47 (Suppl. 01) S255-S260
    CrossrefPubMedGoogle Scholar
  • 48 Altes A, Remacha AF, Sarda P. , et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34 (06) 505-509
    CrossrefPubMedGoogle Scholar
  • 49 Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol 2011; 49 (Suppl. 01) S7-S12
    CrossrefPubMedGoogle Scholar
  • 50 Singh N, Sun HY. Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens. Liver Transpl 2008; 14 (09) 1249-1255
    CrossrefPubMedGoogle Scholar
  • 51 Reed C, Ibrahim A, Edwards Jr JE, Walot I, Spellberg B. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother 2006; 50 (11) 3968-3969
    CrossrefPubMedGoogle Scholar
  • 52 Ibrahim AS, Gebremariam T, Lin L. , et al. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol 2010; 77 (03) 587-604
    CrossrefPubMedGoogle Scholar
  • 53 Boelaert JR, de Locht M, Van Cutsem J. , et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993; 91 (05) 1979-1986
    CrossrefPubMedGoogle Scholar
  • 54 Husni RN, Gordon SM, Longworth DL. , et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26 (03) 753-755
    CrossrefPubMedGoogle Scholar
  • 55 Bhaskaran A, Hosseini-Moghaddam SM, Rotstein C, Husain S. Mold infections in lung transplant recipients. Semin Respir Crit Care Med 2013; 34 (03) 371-379
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Hsu JL, Khan MA, Sobel RA. , et al. Aspergillus fumigatus invasion increases with progressive airway ischemia. PLoS One 2013; 8 (10) e77136
    CrossrefPubMedGoogle Scholar
  • 57 Nazik H, Penner JC, Ferreira JA. , et al. Effects of iron chelators on the formation and development of Aspergillus fumigatus biofilm. Antimicrob Agents Chemother 2015; 59 (10) 6514-6520
    CrossrefPubMedGoogle Scholar
  • 58 Solé A, Morant P, Salavert M, Pemán J, Morales P. ; Valencia Lung Transplant Group. Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect 2005; 11 (05) 359-365
    CrossrefPubMedGoogle Scholar
  • 59 Westney GE, Kesten S, De Hoyos A, Chapparro C, Winton T, Maurer JR. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996; 61 (06) 915-919
    CrossrefPubMedGoogle Scholar
  • 60 Fitton TP, Bethea BT, Borja MC. , et al. Pulmonary resection following lung transplantation. Ann Thorac Surg 2003; 76 (05) 1680-1685 , discussion 1685–1686
    CrossrefPubMedGoogle Scholar
  • 61 Gazzoni FF, Hochhegger B, Severo LC, Camargo JJ. Aspergillus fumigatus fungus ball in the native lung after single lung transplantation. J Bras Pneumol 2013; 39 (03) 393-395
    CrossrefPubMedGoogle Scholar
  • 62 Bains SN, Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med 2012; 33 (02) 265-281
    CrossrefPubMedGoogle Scholar
  • 63 Verleden GM, Dupont LJ, Van Raemdonck DE. ABPA: does it really exist after lung transplantation?. J Heart Lung Transplant 2009; 28 (11) 1239
    CrossrefPubMedGoogle Scholar
  • 64 Fitzsimons EJ, Aris R, Patterson R. Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient. Chest 1997; 112 (01) 281-282
    CrossrefPubMedGoogle Scholar
  • 65 Gordon SM, Avery RK. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl Infect Dis 2001; 3 (03) 161-167
    CrossrefPubMedGoogle Scholar
  • 66 Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003; 22 (03) 258-266
    CrossrefPubMedGoogle Scholar
  • 67 Mehrad B, Paciocco G, Martinez FJ, Ojo TC, Iannettoni MD, Lynch III JP. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119 (01) 169-175
    CrossrefPubMedGoogle Scholar
  • 68 Weigt SS, Copeland CA, Derhovanessian A. , et al. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study. Am J Transplant 2013; 13 (04) 919-927
    CrossrefPubMedGoogle Scholar
  • 69 Fernández-Ruiz M, Silva JT, San-Juan R. , et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore) 2012; 91 (05) 261-273
    CrossrefPubMedGoogle Scholar
  • 70 Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18 (01) 44-69
    CrossrefPubMedGoogle Scholar
  • 71 Nunley DR, Gal AA, Vega JD, Perlino C, Smith P, Lawrence EC. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002; 122 (04) 1185-1191
    CrossrefPubMedGoogle Scholar
  • 72 Solé A, Salavert M. Fungal infections after lung transplantation. Curr Opin Pulm Med 2009; 15 (03) 243-253
    CrossrefPubMedGoogle Scholar
  • 73 Hadjiliadis D, Howell DN, Davis RD. , et al. Anastomotic infections in lung transplant recipients. Ann Transplant 2000; 5 (03) 13-19
    PubMedGoogle Scholar
  • 74 Husain S, Mooney ML, Danziger-Isakov L. , et al; ISHLT Infectious Diseases Council Working Group on Definitions. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011; 30 (04) 361-374
    CrossrefPubMedGoogle Scholar
  • 75 De Pauw B, Walsh TJ, Donnelly JP. , et al; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46 (12) 1813-1821
    CrossrefPubMedGoogle Scholar
  • 76 Sharma S, Gupta P, Gupta N, Lal A, Behera D, Rajwanshi A. Pulmonary infections in immunocompromised patients: the role of image-guided fine needle aspiration cytology. Cytopathology 2017; 28 (01) 46-54
    CrossrefPubMedGoogle Scholar
  • 77 Sharma SK, Kumar S, Singh AK. , et al. Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia. J Infect Dev Ctries 2013; 7 (10) 748-752
    PubMedGoogle Scholar
  • 78 Geltner C, Lass-Flörl C. Invasive pulmonary aspergillosis in organ transplants--Focus on lung transplants. Respir Investig 2016; 54 (02) 76-84
    CrossrefPubMedGoogle Scholar
  • 79 Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42 (10) 1417-1427
    CrossrefPubMedGoogle Scholar
  • 80 Pasqualotto AC, Xavier MO, Sánchez LB. , et al. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation 2010; 90 (03) 306-311
    PubMedGoogle Scholar
  • 81 Zou M, Tang L, Zhao S. , et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One 2012; 7 (08) e43347
    CrossrefPubMedGoogle Scholar
  • 82 Salehi E, Hedayati MT, Zoll J. , et al. Discrimination of aspergillosis, mucormycosis, fusariosis and scedosporiosis in formalin-fixed paraffin-embedded tissue specimens using multiple real-time quantitative PCR assays. J Clin Microbiol 2016; 54 (11) 2798-2803
    CrossrefPubMedGoogle Scholar
  • 83 Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003; 41 (08) 3623-3626
    CrossrefPubMedGoogle Scholar
  • 84 Herbrecht R, Denning DW, Patterson TF. , et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347 (06) 408-415
    CrossrefPubMedGoogle Scholar
  • 85 Limper AH, Knox KS, Sarosi GA. , et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011; 183 (01) 96-128
    CrossrefPubMedGoogle Scholar
  • 86 Patterson TF, Thompson III GR, Denning DW. , et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 63 (04) e1-e60
    CrossrefPubMedGoogle Scholar
  • 87 Malani AN, Kerr LE, Kauffman CA. Voriconazole: how to use this antifungal agent and what to expect. Semin Respir Crit Care Med 2015; 36 (05) 786-795
    Article in Thieme ConnectPubMedGoogle Scholar
  • 88 Maertens JA, Raad II, Marr KA. , et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet 2016; 387 (10020): 760-769
    CrossrefPubMedGoogle Scholar
  • 89 Marr KA, Schlamm HT, Herbrecht R. , et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med 2015; 162 (02) 81-89
    CrossrefPubMedGoogle Scholar
  • 90 Burgel PR, Baixench MT, Amsellem M. , et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother 2012; 56 (02) 869-874
    CrossrefPubMedGoogle Scholar
  • 91 Camps SM, Rijs AJ, Klaassen CH. , et al. Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism. J Clin Microbiol 2012; 50 (08) 2674-2680
    CrossrefPubMedGoogle Scholar
  • 92 van der Linden JW, Camps SM, Kampinga GA. , et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 2013; 57 (04) 513-520
    CrossrefPubMedGoogle Scholar
  • 93 Wiederhold NP, Patterson TF. Emergence of azole resistance in Aspergillus . Semin Respir Crit Care Med 2015; 36 (05) 673-680
    Article in Thieme ConnectPubMedGoogle Scholar
  • 94 Chowdhary A, Sharma C, Kathuria S, Hagen F, Meis JF. Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J Antimicrob Chemother 2014; 69 (02) 555-557
    CrossrefPubMedGoogle Scholar
  • 95 Chowdhary A, Sharma C, van den Boom M. , et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother 2014; 69 (11) 2979-2983
    CrossrefPubMedGoogle Scholar
  • 96 Husain S, Zaldonis D, Kusne S, Kwak EJ, Paterson DL, McCurry KR. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006; 8 (04) 213-218
    CrossrefPubMedGoogle Scholar
  • 97 Bhaskaran A, Mumtaz K, Husain S. Anti-Aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis. Curr Infect Dis Rep 2013; 15 (06) 514-525
    CrossrefPubMedGoogle Scholar
  • 98 Chong PP, Kennedy CC, Hathcock MA, Kremers WK, Razonable RR. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis. Clin Transplant 2015; 29 (04) 311-318
    CrossrefPubMedGoogle Scholar
  • 99 Husain S, Paterson DL, Studer S. , et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006; 6 (12) 3008-3016
    CrossrefPubMedGoogle Scholar
  • 100 Neoh CF, Snell GI, Levvey B. , et al. Preemptive treatment with voriconazole in lung transplant recipients. Transpl Infect Dis 2013; 15 (04) 344-353
    CrossrefPubMedGoogle Scholar
  • 101 Feist A, Lee R, Osborne S, Lane J, Yung G. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole. J Heart Lung Transplant 2012; 31 (11) 1177-1181
    CrossrefPubMedGoogle Scholar
  • 102 Kolaitis NA, Duffy E, Zhang A. , et al. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation. Transpl Int 2017; 30 (01) 41-48
    CrossrefPubMedGoogle Scholar
  • 103 Singer JP, Boker A, Metchnikoff C. , et al. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant 2012; 31 (07) 694-699
    CrossrefPubMedGoogle Scholar
  • 104 Vadnerkar A, Nguyen MH, Mitsani D. , et al. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant 2010; 29 (11) 1240-1244
    CrossrefPubMedGoogle Scholar
  • 105 Girmenia C, Frustaci AM, Gentile G. , et al. Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience. Haematologica 2012; 97 (04) 560-567
    CrossrefPubMedGoogle Scholar
  • 106 Clark NM, Grim SA, Lynch III JP. Posaconazole: use in the prophylaxis and treatment of fungal infections. Semin Respir Crit Care Med 2015; 36 (05) 767-785
    Article in Thieme ConnectPubMedGoogle Scholar
  • 107 Riley TT, Muzny CA, Swiatlo E, Legendre DP. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother 2016; 50 (09) 747-757
    CrossrefPubMedGoogle Scholar
  • 108 Danion F, Aguilar C, Catherinot E. , et al. Mucormycosis: new developments into a persistently devastating infection. Semin Respir Crit Care Med 2015; 36 (05) 692-705
    Article in Thieme ConnectPubMedGoogle Scholar
  • 109 Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis 2012; 54 (Suppl. 01) S8-S15
    CrossrefPubMedGoogle Scholar
  • 110 Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54 (Suppl. 01) S23-S34
    CrossrefPubMedGoogle Scholar
  • 111 Moreira J, Varon A, Galhardo MC. , et al. The burden of mucormycosis in HIV-infected patients: a systematic review. J Infect 2016; 73 (03) 181-188
    CrossrefPubMedGoogle Scholar
  • 112 Roden MM, Zaoutis TE, Buchanan WL. , et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41 (05) 634-653
    CrossrefPubMedGoogle Scholar
  • 113 Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 2011; 24 (02) 411-445
    CrossrefPubMedGoogle Scholar
  • 114 Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med 2011; 32 (06) 693-702
    Article in Thieme ConnectPubMedGoogle Scholar
  • 115 Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13 (02) 236-301
    CrossrefPubMedGoogle Scholar
  • 116 Pyrgos V, Shoham S, Walsh TJ. Pulmonary zygomycosis. Semin Respir Crit Care Med 2008; 29 (02) 111-120
    Article in Thieme ConnectPubMedGoogle Scholar
  • 117 Lazar SP, Lukaszewicz JM, Persad KA, Reinhardt JF. Rhinocerebral Mucor circinelloides infection in immunocompromised patient following yogurt ingestion. Del Med J 2014; 86 (08) 245-248
    PubMedGoogle Scholar
  • 118 Lee SC, Billmyre RB, Li A. , et al. Analysis of a food-borne fungal pathogen outbreak: virulence and genome of a Mucor circinelloides isolate from yogurt. MBio 2014; 5 (04) e01390-e14
    PubMedGoogle Scholar
  • 119 Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect 2009; 15 (Suppl. 05) 55-59
    PubMedGoogle Scholar
  • 120 Hopkins MA, Treloar DM. Mucormycosis in diabetes. Am J Crit Care 1997; 6 (05) 363-367
    CrossrefPubMedGoogle Scholar
  • 121 Chakrabarti A, Das A, Mandal J. , et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006; 44 (04) 335-342
    CrossrefPubMedGoogle Scholar
  • 122 Saedi B, Sadeghi M, Seilani P. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B. J Laryngol Otol 2011; 125 (08) 807-810
    CrossrefPubMedGoogle Scholar
  • 123 Kontoyiannis DP, Lionakis MS, Lewis RE. , et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191 (08) 1350-1360
    CrossrefPubMedGoogle Scholar
  • 124 Dimaka K, Mallis A, Naxakis SS. , et al. Chronic rhinocerebral mucormycosis: a rare case report and review of the literature. Mycoses 2014; 57 (11) 699-702
    CrossrefPubMedGoogle Scholar
  • 125 Chretien ML, Legouge C, Pagès PB. , et al. Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre. Clin Microbiol Infect 2016; 22 (09) 782-787
    CrossrefPubMedGoogle Scholar
  • 126 Chamilos G, Luna M, Lewis RE. , et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica 2006; 91 (07) 986-989
    PubMedGoogle Scholar
  • 127 Lanternier F, Dannaoui E, Morizot G. , et al; French Mycosis Study Group. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 2012; 54 (Suppl. 01) S35-S43
    CrossrefPubMedGoogle Scholar
  • 128 Pana ZD, Seidel D, Skiada A. , et al; Collaborators of Zygomyco.net and/or FungiScope™ Registries*. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis 2016; 16 (01) 667
    CrossrefPubMedGoogle Scholar
  • 129 Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases?. Leuk Lymphoma 2004; 45 (07) 1351-1360
    CrossrefPubMedGoogle Scholar
  • 130 Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47 (04) 503-509
    CrossrefPubMedGoogle Scholar
  • 131 Kreiniz N, Bejar J, Polliack A, Tadmor T. Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma. Hematol Oncol 2017
    PubMedGoogle Scholar
  • 132 Kennedy KJ, Daveson K, Slavin MA. , et al; Australia and New Zealand Mycoses Interest Group of the Australasian Society for Infectious Diseases. Mucormycosis in Australia: contemporary epidemiology and outcomes. Clin Microbiol Infect 2016; 22 (09) 775-781
    CrossrefPubMedGoogle Scholar
  • 133 Weng DE, Wilson WH, Little R, Walsh TJ. Successful medical management of isolated renal zygomycosis: case report and review. Clin Infect Dis 1998; 26 (03) 601-605
    CrossrefPubMedGoogle Scholar
  • 134 Moreira J, Ridolfi F, Almeida-Paes R, Varon A, Lamas CC. Cutaneous mucormycosis in advanced HIV disease. Braz J Infect Dis 2016; 20 (06) 637-640
    CrossrefPubMedGoogle Scholar
  • 135 Ahmed Y, Delaney S, Markarian A. Successful isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome. Am J Otolaryngol 2016; 37 (02) 152-155
    CrossrefPubMedGoogle Scholar
  • 136 Kutlu M, Ergin C, Bir F. , et al. Pulmonary mucormycosis due to Lichtheimia ramosa in a patient with HIV infection. Mycopathologia 2014; 178 (1-2): 111-115
    CrossrefPubMedGoogle Scholar
  • 137 Rathi M, Sengupta U, Yadav TD, Kumar S. Zygomycetes peritonitis in ambulatory peritoneal dialysis: case report and review of literature. Indian J Nephrol 2014; 24 (04) 252-254
    CrossrefPubMedGoogle Scholar
  • 138 Ram R, Swarnalatha G, Prasad N, Dakshinamurty KV. Exit site infection due to zygomycosis resulting in abdominal wall necrosis in a continuous ambulatory peritoneal dialysis patient. Nephrol Dial Transplant 2007; 22 (01) 266-267
    PubMedGoogle Scholar
  • 139 Sedlacek M, Cotter JG, Suriawinata AA. , et al. Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis 2008; 51 (02) 302-306
    CrossrefPubMedGoogle Scholar
  • 140 Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350 (09) 950-952
    CrossrefPubMedGoogle Scholar
  • 141 Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39 (05) 743-746
    CrossrefPubMedGoogle Scholar
  • 142 Trifilio SM, Bennett CL, Yarnold PR. , et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007; 39 (07) 425-429
    CrossrefPubMedGoogle Scholar
  • 143 Chander J, Singla N, Kaur M. , et al. Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections - a study from a tertiary care hospital in north India. Infect Dis (Lond) 2017; 49 (03) 170-177
    CrossrefPubMedGoogle Scholar
  • 144 Warkentien T, Rodriguez C, Lloyd B. , et al; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group. Invasive mold infections following combat-related injuries. Clin Infect Dis 2012; 55 (11) 1441-1449
    CrossrefPubMedGoogle Scholar
  • 145 Tyll T, Lyskova P, Hubka V. , et al. Early diagnosis of cutaneous mucormycosis due to Lichtheimia corymbifera after a traffic accident. Mycopathologia 2016; 181 (1-2): 119-124
    CrossrefPubMedGoogle Scholar
  • 146 Kontoyiannis DP, Marr KA, Park BJ. , et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 2010; 50 (08) 1091-1100
    CrossrefPubMedGoogle Scholar
  • 147 Sun HY, Forrest G, Gupta KL. , et al. Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation 2010; 90 (01) 85-92
    CrossrefPubMedGoogle Scholar
  • 148 Guimarães LF, Halpern M, de Lemos AS. , et al. Invasive fungal disease in renal transplant recipients at a Brazilian center: local epidemiology matters. Transplant Proc 2016; 48 (07) 2306-2309
    CrossrefPubMedGoogle Scholar
  • 149 Rabin AS, Givertz MM, Couper GS. , et al. Risk factors for invasive fungal disease in heart transplant recipients. J Heart Lung Transplant 2015; 34 (02) 227-232
    CrossrefPubMedGoogle Scholar
  • 150 Abboud CS, Bergamasco MD, Baía CE. , et al. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy. Transplant Proc 2012; 44 (08) 2501-2502
    CrossrefPubMedGoogle Scholar
  • 151 Deyo JC, Nicolsen N, Lachiewicz A, Kozlowski T. Salvage treatment of mucormycosis post-liver transplant with posaconazole during sirolimus maintenance immunosuppression. J Pharm Pract 2017; 30 (02) 261-265
    CrossrefPubMedGoogle Scholar
  • 152 Do GW, Jung SW, Jun JB, Seo JH, Nah YW. Colonic mucormycosis presented with ischemic colitis in a liver transplant recipient. World J Gastroenterol 2013; 19 (22) 3508-3511
    CrossrefPubMedGoogle Scholar
  • 153 Ramos A, Cuervas-Mons V, Noblejas A. , et al. Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. Transplant Proc 2009; 41 (05) 1972-1975
    CrossrefPubMedGoogle Scholar
  • 154 Vondran FW, Knitsch W, Krech T. , et al. Intestinal mucormycosis with Rhizopus microsporus after liver transplantation--successful treatment of a rare but life-threatening complication. Transplantation 2014; 97 (02) e11-e13
    CrossrefPubMedGoogle Scholar
  • 155 García-Pajares F, Sánchez-Antolín G, Almohalla Alvárez C. , et al. Cutaneous mucormycosis infection by Absidia in two consecutive liver transplant patients. Transplant Proc 2012; 44 (06) 1562-1564
    CrossrefPubMedGoogle Scholar
  • 156 Farojov R, Aydın O, Yılmaz C. , et al. Rhino-orbita-maxillary mucormycosis after liver transplantation: a case report. Transplant Proc 2016; 48 (09) 3210-3213
    CrossrefPubMedGoogle Scholar
  • 157 Nam Y, Jung J, Park SS. , et al. Disseminated mucormycosis with myocardial involvement in a renal transplant recipient. Transpl Infect Dis 2015; 17 (06) 890-896
    CrossrefPubMedGoogle Scholar
  • 158 Tan M, Gibney EM. Lung mass in a kidney transplant recipient. Am J Transplant 2015; 15 (01) 281-282 , quiz 283
    CrossrefPubMedGoogle Scholar
  • 159 Davuodi S, Manshadi SA, Salehi MR, Yazdi F, Khazravi M, Fazli JT. Fatal cutaneous mucormycosis after kidney transplant. Exp Clin Transplant 2015; 13 (01) 82-85
    PubMedGoogle Scholar
  • 160 Ville S, Talarmin JP, Gaultier-Lintia A. , et al. Disseminated mucormycosis with cerebral involvement owing to Rhizopus microsporus in a kidney recipient treated with combined liposomal amphotericin B and posaconazole therapy. Exp Clin Transplant 2016; 14 (01) 96-99
    PubMedGoogle Scholar
  • 161 Barnajian M, Gioia W, Iordache F, Bergamaschi R. Mucormycosis-induced colon perforation after renal transplantation. Surg Infect (Larchmt) 2014; 15 (05) 665-666
    CrossrefPubMedGoogle Scholar
  • 162 Zhu X, Liu H, Wang W. , et al. Two cases of transplant renal artery thrombosis and spontaneous rupture caused by mucormycosis. Transpl Infect Dis 2015; 17 (03) 442-448
    CrossrefPubMedGoogle Scholar
  • 163 Tobón AM, Arango M, Fernández D, Restrepo A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 2003; 36 (11) 1488-1491
    CrossrefPubMedGoogle Scholar
  • 164 Navanukroh O, Jitmuang A, Chayakulkeeree M, Ngamskulrungroj P. Disseminated Cunninghamella bertholletiae infection with spinal epidural abscess in a kidney transplant patient: case report and literature review. Transpl Infect Dis 2014; 16 (04) 658-665
    CrossrefPubMedGoogle Scholar
  • 165 Park W, Jang M, Hwang E. , et al. Allograft mucormycosis due to Rhizopus microsporus in a kidney transplant recipient. Transplant Proc 2014; 46 (02) 623-625
    CrossrefPubMedGoogle Scholar
  • 166 Lee E, Vershvovsky Y, Miller F, Waltzer W, Suh H, Nord EP. Combined medical surgical therapy for pulmonary mucormycosis in a diabetic renal allograft recipient. Am J Kidney Dis 2001; 38 (06) E37
    CrossrefPubMedGoogle Scholar
  • 167 Tan HP, Razzouk A, Gundry SR, Bailey L. Pulmonary Rhizopus rhizopodiformis cavitary abscess in a cardiac allograft recipient. J Cardiovasc Surg (Torino) 1999; 40 (02) 223-226
    PubMedGoogle Scholar
  • 168 Kfoury AG, Smith JC, Farhoud HH. , et al. Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient. Clin Transplant 1997; 11 (06) 608-612
    PubMedGoogle Scholar
  • 169 Zander DS, Cicale MJ, Mergo P. Durable cure of mucormycosis involving allograft and native lungs. J Heart Lung Transplant 2000; 19 (06) 615-618
    CrossrefPubMedGoogle Scholar
  • 170 Page AV, Evans AJ, Snell L, Liles WC. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis 2008; 10 (06) 419-425
    CrossrefPubMedGoogle Scholar
  • 171 Silveira FP, Kwak EJ, Paterson DL, Pilewski JM, McCurry KR, Husain S. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant 2008; 27 (08) 850-855
    CrossrefPubMedGoogle Scholar
  • 172 Langford S, Trubiano JA, Saxon S, Spelman D, Morrissey CO. mucormycete infection or colonisation: experience of an Australian tertiary referral centre. Mycoses 2016; 59 (05) 291-295
    CrossrefPubMedGoogle Scholar
  • 173 Bitar D, Lortholary O, Le Strat Y. , et al. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 2014; 20 (07) 1149-1155
    CrossrefPubMedGoogle Scholar
  • 174 Bitar D, Van Cauteren D, Lanternier F. , et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 2009; 15 (09) 1395-1401
    CrossrefPubMedGoogle Scholar
  • 175 Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K. Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis 2010; 16 (09) 1456-1458
    CrossrefPubMedGoogle Scholar
  • 176 Kontoyiannis DP, Yang H, Song J. , et al. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis 2016; 16 (01) 730
    CrossrefPubMedGoogle Scholar
  • 177 Zilberberg MD, Shorr AF, Huang H, Chaudhari P, Paly VF, Menzin J. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis 2014; 14: 310
    CrossrefPubMedGoogle Scholar
  • 178 Pagano L, Caira M, Nosari A. , et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45 (09) 1161-1170
    CrossrefPubMedGoogle Scholar
  • 179 Li H, Hwang SK, Zhou C, Du J, Zhang J. Gangrenous cutaneous mucormycosis caused by Rhizopus oryzae: a case report and review of primary cutaneous mucormycosis in China over past 20 years. Mycopathologia 2013; 176 (1-2): 123-128
    CrossrefPubMedGoogle Scholar
  • 180 Chan Y, Goldwater P, Saxon B. Successful treatment of cutaneous and subcutaneous zygomycosis in an immunosuppressed patient with aplastic anaemia. J Paediatr Child Health 2007; 43 (1-2): 87-89
    CrossrefPubMedGoogle Scholar
  • 181 Tathe SP, Dani AA, Chawhan SM, Meshram SA, Randale AA, Raut WK. Gastric mucormycosis: diagnosis by imprint cytology. Diagn Cytopathol 2016; 44 (10) 820-822
    CrossrefPubMedGoogle Scholar
  • 182 Bernardo RM, Gurung A, Jain D, Malinis MF. Therapeutic challenges of hepatic mucormycosis in hematologic malignancy: a case report and review of the literature. Am J Case Rep 2016; 17: 484-489
    CrossrefPubMedGoogle Scholar
  • 183 Manesh A, John AO, Mathew B. , et al. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis. Mycoses 2016
    PubMedGoogle Scholar
  • 184 Giudice G, Cutrignelli DA, Sportelli P. , et al. Rhinocerebral mucormycosis with orosinusal involvement: diagnostic and surgical treatment guidelines. Endocr Metab Immune Disord Drug Targets 2016; 16 (04) 264-269
    PubMedGoogle Scholar
  • 185 Mattingly JK, Ramakrishnan VR. Rhinocerebral mucormycosis of the optic nerve. Otolaryngol Head Neck Surg 2016; 155 (05) 888-889
    CrossrefPubMedGoogle Scholar
  • 186 Vogt N, Heß K, Bialek R. , et al. Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemia. Ann Hematol 2017; 96 (01) 151-153
    CrossrefPubMedGoogle Scholar
  • 187 Palejwala SK, Zangeneh TT, Goldstein SA, Lemole GM. An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis. Surg Neurol Int 2016; 7: 61
    PubMedGoogle Scholar
  • 188 Mulki R, Masab M, Eiger G, Perloff S. Lethargy and vision loss: successful management of rhinocerebral mucormycosis. BMJ Case Rep 2016;2016
    PubMedGoogle Scholar
  • 189 Andrey DO, Kaiser L, Emonet S, Erard V, Chalandon Y, van Delden C. Cerebral rhizomucor infection treated by posaconazole delayed-release tablets in an allogeneic stem cell transplant recipient. Int J Infect Dis 2017; 55: 24-26
    CrossrefPubMedGoogle Scholar
  • 190 Cornely OA, Arikan-Akdagli S, Dannaoui E. , et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014; 20 (Suppl. 03) 5-26
    CrossrefPubMedGoogle Scholar
  • 191 Skiada A, Lanternier F, Groll AH. , et al; European Conference on Infections in Leukemia. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013; 98 (04) 492-504
    CrossrefPubMedGoogle Scholar
  • 192 McAdams HP, Rosado de Christenson M, Strollo DC, Patz Jr EF. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol 1997; 168 (06) 1541-1548
    CrossrefPubMedGoogle Scholar
  • 193 Coffey MJ, Fantone III J, Stirling MC, Lynch III JP. Pseudoaneurysm of pulmonary artery in mucormycosis. Radiographic characteristics and management. Am Rev Respir Dis 1992; 145 (06) 1487-1490
    CrossrefPubMedGoogle Scholar
  • 194 Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994; 57 (04) 1044-1050
    CrossrefPubMedGoogle Scholar
  • 195 Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. ; Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Transplantation 2000; 70 (01) 112-116
    PubMedGoogle Scholar
  • 196 Lin CY, Liu WL, Chang CC. , et al. Invasive fungal tracheobronchitis in mechanically ventilated critically ill patients: underlying conditions, diagnosis, and outcomes. Ann Intensive Care 2017; 7 (01) 9
    CrossrefPubMedGoogle Scholar
  • 197 Lelievre L, Garcia-Hermoso D, Abdoul H. , et al; French Mycosis Study Group. Posttraumatic mucormycosis: a nationwide study in France and review of the literature. Medicine (Baltimore) 2014; 93 (24) 395-404
    CrossrefPubMedGoogle Scholar
  • 198 Ingram PR, Suthananthan AE, Rajan R. , et al. Cutaneous mucormycosis and motor vehicle accidents: findings from an Australian case series. Med Mycol 2014; 52 (08) 819-825
    CrossrefPubMedGoogle Scholar
  • 199 Neblett Fanfair R, Benedict K, Bos J. , et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med 2012; 367 (23) 2214-2225
    CrossrefPubMedGoogle Scholar
  • 200 Snell BJ, Tavakoli K. Necrotizing fasciitis caused by Apophysomyces elegans complicating soft-tissue and pelvic injuries in a tsunami survivor from Thailand. Plast Reconstr Surg 2007; 119 (01) 448-449
    CrossrefPubMedGoogle Scholar
  • 201 Austin CL, Finley PJ, Mikkelson DR, Tibbs B. Mucormycosis: a rare fungal infection in tornado victims. J Burn Care Res 2014; 35 (03) e164-e171
    CrossrefPubMedGoogle Scholar
  • 202 Hicks Jr WL, Nowels K, Troxel J. Primary cutaneous mucormycosis. Am J Otolaryngol 1995; 16 (04) 265-268
    CrossrefPubMedGoogle Scholar
  • 203 Ledgard JP, van Hal S, Greenwood JE. Primary cutaneous zygomycosis in a burns patient: a review. J Burn Care Res 2008; 29 (02) 286-290
    CrossrefPubMedGoogle Scholar
  • 204 Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med 2001; 125 (03) 375-378
    PubMedGoogle Scholar
  • 205 Haas BM, Clayton JD, Elicker BM, Ordovas KG, Naeger DM. CT-guided percutaneous lung biopsies in patients with suspicion for infection may yield clinically useful information. AJR Am J Roentgenol 2017; 208 (02) 459-463
    CrossrefPubMedGoogle Scholar
  • 206 Shigemura T, Nishina S, Nakazawa H, Matsuda K, Yaguchi T, Nakazawa Y. Early detection of Rhizopus DNA in the serum of a patient with rhino-orbital-cerebral mucormycosis following allogeneic hematopoietic stem cell transplantation. Int J Hematol 2016; 103 (03) 354-355
    CrossrefPubMedGoogle Scholar
  • 207 Millon L, Larosa F, Lepiller Q. , et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis 2013; 56 (10) e95-e101
    CrossrefPubMedGoogle Scholar
  • 208 Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis 2012; 54 (Suppl. 01) S55-S60
    CrossrefPubMedGoogle Scholar
  • 209 Rickerts V, Mousset S, Lambrecht E. , et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 2007; 44 (08) 1078-1083
    CrossrefPubMedGoogle Scholar
  • 210 Bialek R, Konrad F, Kern J. , et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005; 58 (11) 1180-1184
    CrossrefPubMedGoogle Scholar
  • 211 Lackner M, Caramalho R, Lass-Flörl C. Laboratory diagnosis of mucormycosis: current status and future perspectives. Future Microbiol 2014; 9 (05) 683-695
    CrossrefPubMedGoogle Scholar
  • 212 Rüping MJ, Heinz WJ, Kindo AJ. , et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010; 65 (02) 296-302
    CrossrefPubMedGoogle Scholar
  • 213 Neofytos D, Horn D, Anaissie E. , et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48 (03) 265-273
    CrossrefPubMedGoogle Scholar
  • 214 Tissot F, Agrawal S, Pagano L. , et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica 2017; 102 (03) 433-444
    CrossrefPubMedGoogle Scholar
  • 215 Marty FM, Ostrosky-Zeichner L, Cornely OA. , et al; VITAL and FungiScope Mucormycosis Investigators. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis 2016; 16 (07) 828-837
    CrossrefPubMedGoogle Scholar
  • 216 Pfaller MA, Messer SA, Hollis RJ, Jones RN. ; SENTRY Participants Group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002; 46 (04) 1032-1037
    CrossrefPubMedGoogle Scholar
  • 217 Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus . Med Mycol 2008; 46 (06) 567-573
    CrossrefPubMedGoogle Scholar
  • 218 Petrikkos GL. Lipid formulations of amphotericin B as first-line treatment of zygomycosis. Clin Microbiol Infect 2009; 15 (Suppl. 05) 87-92
    PubMedGoogle Scholar
  • 219 Yoon YK, Kim MJ, Chung YG, Shin IY. Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole. J Korean Neurosurg Soc 2010; 47 (01) 74-77
    CrossrefPubMedGoogle Scholar
  • 220 Greenberg RN, Mullane K, van Burik JA. , et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50 (01) 126-133
    CrossrefPubMedGoogle Scholar
  • 221 van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42 (07) e61-e65
    CrossrefPubMedGoogle Scholar
  • 222 Vehreschild JJ, Birtel A, Vehreschild MJ. , et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013; 39 (03) 310-324
    CrossrefPubMedGoogle Scholar
  • 223 Epstein JB, Kupferman SB, Zabner R. , et al. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Support Care Cancer 2016; 24 (08) 3343-3346
    CrossrefPubMedGoogle Scholar
  • 224 Ashkenazi-Hoffnung L, Bilavsky E, Avitzur Y, Amir J. Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient. Transplantation 2010; 90 (10) 1133-1135
    CrossrefPubMedGoogle Scholar
  • 225 Ananda-Rajah MR, Kontoyiannis D. Isavuconazole: a new extended spectrum triazole for invasive mold diseases. Future Microbiol 2015; 10 (05) 693-708
    CrossrefPubMedGoogle Scholar
  • 226 Tacke D, Koehler P, Markiefka B, Cornely OA. Our 2014 approach to mucormycosis. Mycoses 2014; 57 (09) 519-524
    CrossrefPubMedGoogle Scholar
  • 227 Pagano L, Caira M, Candoni A. , et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91 (08) 1068-1075
    PubMedGoogle Scholar
  • 228 Kyvernitakis A, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect 2016; 22 (09) 811.e1-811.e8
    CrossrefPubMedGoogle Scholar
  • 229 Spellberg B, Ibrahim AS, Chin-Hong PV. , et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012; 67 (03) 715-722
    CrossrefPubMedGoogle Scholar
  • 230 Mitchell TA, Hardin MO, Murray CK. , et al. Mucormycosis attributed mortality: a seven-year review of surgical and medical management. Burns 2014; 40 (08) 1689-1695
    CrossrefPubMedGoogle Scholar
  • 231 Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev 2010; 23 (04) 884-928
    CrossrefPubMedGoogle Scholar
  • 232 Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009; 48 (08) 1033-1041
    CrossrefPubMedGoogle Scholar
  • 233 Boyce RD, Deziel PJ, Otley CC. , et al. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis 2010; 12 (03) 242-250
    PubMedGoogle Scholar
  • 234 Farina C, Gotti E, Parma A, Naldi L, Goglio A. Pheohyphomycotic soft tissue disease caused by Alternaria alternata in a kidney transplant patient: a case report and literature review. Transplant Proc 2007; 39 (05) 1655-1659
    CrossrefPubMedGoogle Scholar
  • 235 Chandramukhi A, Ramadevi MG, Shankar SK. Cerebral cladosporiosis--a neuropathological and microbiological study. Clin Neurol Neurosurg 1983; 85 (04) 245-253
    CrossrefPubMedGoogle Scholar
  • 236 Crichlow DK, Enrile FT, Memon MY. Cerebellar abscess due to Cladosporium trichoides (bantianum): case report. Am J Clin Pathol 1973; 60 (03) 416-421
    CrossrefPubMedGoogle Scholar
  • 237 Fan YM, Huang WM, Li SF, Wu GF, Li W, Chen RY. Cutaneous phaeohyphomycosis of foot caused by Curvularia clavata . Mycoses 2009; 52 (06) 544-546
    CrossrefPubMedGoogle Scholar
  • 238 Fernandez M, Noyola DE, Rossmann SN, Edwards MS. Cutaneous phaeohyphomycosis caused by Curvularia lunata and a review of Curvularia infections in pediatrics. Pediatr Infect Dis J 1999; 18 (08) 727-731
    CrossrefPubMedGoogle Scholar
  • 239 Chowdhary A, Meis JF, Guarro J. , et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 2014; 20 (Suppl. 03) 47-75
    CrossrefPubMedGoogle Scholar
  • 240 Bhat SV, Paterson DL, Rinaldi MG, Veldkamp PJ. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007; 39 (01) 87-90
    CrossrefPubMedGoogle Scholar
  • 241 Cortez KJ, Roilides E, Quiroz-Telles F. , et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21 (01) 157-197
    CrossrefPubMedGoogle Scholar
  • 242 Lackner M, Hagen F, Meis JF. , et al. Susceptibility and diversity in the therapy-refractory genus Scedosporium . Antimicrob Agents Chemother 2014; 58 (10) 5877-5885
    CrossrefPubMedGoogle Scholar
  • 243 Harun A, Perdomo H, Gilgado F. , et al. Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol 2009; 47 (04) 406-414
    CrossrefPubMedGoogle Scholar
  • 244 Panackal AA, Marr KA. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med 2004; 25 (02) 171-181
    Article in Thieme ConnectPubMedGoogle Scholar
  • 245 Campagnaro EL, Woodside KJ, Early MG. , et al. Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient. Transpl Infect Dis 2002; 4 (04) 207-211
    CrossrefPubMedGoogle Scholar
  • 246 Gilgado F, Cano J, Gené J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43 (10) 4930-4942
    CrossrefPubMedGoogle Scholar
  • 247 Delhaes L, Harun A, Chen SC. , et al; Australian Scedosporium (AUSCEDO) Study Group. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum . Emerg Infect Dis 2008; 14 (02) 282-290
    CrossrefPubMedGoogle Scholar
  • 248 Tamaki M, Nozaki K, Onishi M, Yamamoto K, Ujiie H, Sugahara H. Fungal meningitis caused by Lomentospora prolificans after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2016; 18 (04) 601-605
    CrossrefPubMedGoogle Scholar
  • 249 Rougeron A, Schuliar G, Leto J. , et al. Human-impacted areas of France are environmental reservoirs of the Pseudallescheria boydii/Scedosporium apiospermum species complex. Environ Microbiol 2015; 17 (04) 1039-1048
    CrossrefPubMedGoogle Scholar
  • 250 Kaltseis J, Rainer J, De Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol 2009; 47 (04) 398-405
    CrossrefPubMedGoogle Scholar
  • 251 Harun A, Gilgado F, Chen SC, Meyer W. Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis. Med Mycol 2010; 48 (Suppl. 01) S70-S76
    CrossrefPubMedGoogle Scholar
  • 252 Heath CH, Slavin MA, Sorrell TC. , et al; Australian Scedosporium Study Group. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 2009; 15 (07) 689-693
    CrossrefPubMedGoogle Scholar
  • 253 Zouhair R, Rougeron A, Razafimandimby B, Kobi A, Bouchara JP, Giraud S. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis. Med Mycol 2013; 51 (06) 603-613
    CrossrefPubMedGoogle Scholar
  • 254 Rodriguez-Tudela JL, Berenguer J, Guarro J. , et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009; 47 (04) 359-370
    CrossrefPubMedGoogle Scholar
  • 255 Symoens F, Knoop C, Schrooyen M. , et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25 (05) 603-607
    CrossrefPubMedGoogle Scholar
  • 256 Padoan R, Poli P, Colombrita D, Borghi E, Timpano S, Berlucchi M. Acute Scedosporium apiospermum endobronchial infection in cystic fibrosis. Pediatr Infect Dis J 2016; 35 (06) 701-702
    CrossrefPubMedGoogle Scholar
  • 257 Troke P, Aguirrebengoa K, Arteaga C. , et al; Global Scedosporium Study Group. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 2008; 52 (05) 1743-1750
    CrossrefPubMedGoogle Scholar
  • 258 Idigoras P, Pérez-Trallero E, Piñeiro L. , et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990–1999. Clin Infect Dis 2001; 32 (11) E158-E165
    CrossrefPubMedGoogle Scholar
  • 259 Berenguer J, Rodríguez-Tudela JL, Richard C. , et al; Scedosporium prolificans Spanish Study Group. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Medicine (Baltimore) 1997; 76 (04) 256-265
    CrossrefPubMedGoogle Scholar
  • 260 Leek R, Aldag E, Nadeem I. , et al. Scedosporiosis in a combined kidney and liver transplant recipient: a case report of possible transmission from a near-drowning donor. Case Rep Transplant 2016; 2016: 1879529
    PubMedGoogle Scholar
  • 261 Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis 2014; 16 (04) 578-587
    CrossrefPubMedGoogle Scholar
  • 262 Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002; 81 (05) 333-348
    CrossrefPubMedGoogle Scholar
  • 263 Tammer I, Tintelnot K, Braun-Dullaeus RC. , et al. Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease–a diagnostic and therapeutic challenge. Int J Infect Dis 2011; 15 (06) e422-e429
    CrossrefPubMedGoogle Scholar
  • 264 Sarva ST, Manjunath SK, Baldwin HS, Robins DB, Freire AX. Lung scedosporiosis in human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Med Sci 2010; 339 (03) 300-303
    CrossrefPubMedGoogle Scholar
  • 265 Kim SH, Ha YE, Youn JC. , et al. Fatal scedosporiosis in multiple solid organ allografts transmitted from a nearly-drowned donor. Am J Transplant 2015; 15 (03) 833-840
    CrossrefPubMedGoogle Scholar
  • 266 Cruysmans C, Rodriguez-Villalobos H, Fomekong E, Dumitriu D, Nassogne MC, Van der Linden D. Epidural abscess caused by Scedosporium apiospermum in an immunocompetent child. Pediatr Infect Dis J 2015; 34 (11) 1277-1278
    CrossrefPubMedGoogle Scholar
  • 267 Patel R, Orlandi RR. Fungal septal abscess complicating maxillary sinus fungus balls in an immunocompetent host. Allergy Rhinol (Providence) 2015; 6 (03) 184-187
    CrossrefPubMedGoogle Scholar
  • 268 Tirado-Miranda R, Solera-Santos J, Brasero JC, Haro-Estarriol M, Cascales-Sánchez P, Igualada JB. Septic arthritis due to Scedosporium apiospermum: case report and review. J Infect 2001; 43 (03) 210-212
    CrossrefPubMedGoogle Scholar
  • 269 Taj-Aldeen SJ, Rammaert B, Gamaletsou M. , et al; International Osteoarticular Mycoses Consortium. Osteoarticular infections caused by non-Aspergillus filamentous fungi in adult and pediatric patients: a systematic review. Medicine (Baltimore) 2015; 94 (50) e2078
    CrossrefPubMedGoogle Scholar
  • 270 Baumgartner BJ, Rakita RM, Backous DD. Scedosporium apiospermum otomycosis. Am J Otolaryngol 2007; 28 (04) 254-256
    CrossrefPubMedGoogle Scholar
  • 271 Bhally HS, Shields C, Lin SY, Merz WG. Otitis caused by Scedosporium apiospermum in an immunocompetent child. Int J Pediatr Otorhinolaryngol 2004; 68 (07) 975-978
    CrossrefPubMedGoogle Scholar
  • 272 Karaarslan A, Arikan S, Karaarslan F, Cetin ES. Skin infection caused by Scedosporium apiospermum . Mycoses 2003; 46 (11-12): 524-526
    CrossrefPubMedGoogle Scholar
  • 273 Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E. Scedosporium apiospermum infection after near-drowning. Mycoses 2007; 50 (05) 412-421
    CrossrefPubMedGoogle Scholar
  • 274 He XH, Wu JY, Wu CJ, Halm-Lutterodt NV, Zhang J, Li CS. Scedosporium Apiospermum infection after near-drowning. Chin Med J (Engl) 2015; 128 (15) 2119-2123
    CrossrefPubMedGoogle Scholar
  • 275 Buzina W, Feierl G, Haas D. , et al. Lethal brain abscess due to the fungus Scedosporium apiospermum (teleomorph Pseudallescheria boydii) after a near-drowning incident: case report and review of the literature. Med Mycol 2006; 44 (05) 473-477
    CrossrefPubMedGoogle Scholar
  • 276 Chaney S, Gopalan R, Berggren RE. Pulmonary Pseudallescheria boydii infection with cutaneous zygomycosis after near drowning. South Med J 2004; 97 (07) 683-687
    CrossrefPubMedGoogle Scholar
  • 277 Leechawengwongs M, Milindankura S, Liengudom A, Chanakul K, Viranuvatti K, Clongsusuek P. Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report. Mycoses 2007; 50 (06) 512-516
    CrossrefPubMedGoogle Scholar
  • 278 Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989–2006. Clin Infect Dis 2006; 43 (12) 1580-1584
    CrossrefPubMedGoogle Scholar
  • 279 Uenotsuchi T, Moroi Y, Urabe K. , et al. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol 2005; 85 (02) 156-159
    CrossrefPubMedGoogle Scholar
  • 280 Yao M, Messner AH. Fungal malignant otitis externa due to Scedosporium apiospermum . Ann Otol Rhinol Laryngol 2001; 110 (04) 377-380
    CrossrefPubMedGoogle Scholar
  • 281 Kim DY, Moon HI, Joe SG, Kim JG, Yoon YH, Lee JY. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea. J Korean Med Sci 2015; 30 (07) 960-964
    CrossrefPubMedGoogle Scholar
  • 282 Vagefi MR, Kim ET, Alvarado RG, Duncan JL, Howes EL, Crawford JB. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol 2005; 139 (02) 370-373
    CrossrefPubMedGoogle Scholar
  • 283 Fortún J, Martín-Dávila P, Sánchez MA. , et al. Voriconazole in the treatment of invasive mold infections in transplant recipients. Eur J Clin Microbiol Infect Dis 2003; 22 (07) 408-413
    CrossrefPubMedGoogle Scholar
  • 284 Kiratli H, Uzun O, Kiraz N, Eldem B. Scedosporium apiospermum chorioretinitis. Acta Ophthalmol Scand 2001; 79 (05) 540-542
    CrossrefPubMedGoogle Scholar
  • 285 Reinoso R, Carreño E, Hileeto D. , et al. Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia. Diagn Microbiol Infect Dis 2013; 76 (03) 375-378
    CrossrefPubMedGoogle Scholar
  • 286 Shinohara MM, George E. Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes. J Cutan Pathol 2009; 36 (Suppl. 01) 39-41
    PubMedGoogle Scholar
  • 287 Pihet M, Carrere J, Cimon B. , et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis–a review. Med Mycol 2009; 47 (04) 387-397
    CrossrefPubMedGoogle Scholar
  • 288 Paugam A, Baixench MT, Demazes-Dufeu N. , et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 2010; 48 (Suppl. 01) S32-S36
    CrossrefPubMedGoogle Scholar
  • 289 Sedlacek L, Graf B, Schwarz C. , et al. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. J Cyst Fibros 2015; 14 (02) 237-241
    CrossrefPubMedGoogle Scholar
  • 290 Cimon B, Carrère J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19 (01) 53-56
    CrossrefPubMedGoogle Scholar
  • 291 Ziesing S, Suerbaum S, Sedlacek L. Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. Med Mycol 2016; 54 (08) 781-786
    CrossrefPubMedGoogle Scholar
  • 292 Russell GK, Gadhok R, Simmonds NJ. The destructive combination of Scedosporium apiospermum lung disease and exuberant inflammation in cystic fibrosis. Paediatr Respir Rev 2013; 14 (Suppl. 01) 22-25
    PubMedGoogle Scholar
  • 293 Nenoff P, Gütz U, Tintelnot K. , et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996; 39 (11-12): 461-465
    CrossrefPubMedGoogle Scholar
  • 294 Maertens J, Lagrou K, Deweerdt H. , et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol 2000; 79 (06) 340-344
    CrossrefPubMedGoogle Scholar
  • 295 Caira M, Girmenia C, Valentini CG. , et al. Scedosporiosis in patients with acute leukemia: a retrospective multicenter report. Haematologica 2008; 93 (01) 104-110
    CrossrefPubMedGoogle Scholar
  • 296 Nishimori M, Takahashi T, Suzuki E. , et al. Fatal fungemia with Scedosporium prolificans in a patient with acute myeloid leukemia. Med Mycol J 2014; 55 (04) E63-E70
    PubMedGoogle Scholar
  • 297 Ochi Y, Hiramoto N, Takegawa H. , et al. Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy. Int J Hematol 2015; 101 (06) 620-625
    CrossrefPubMedGoogle Scholar
  • 298 Alvarez M, Lopez Ponga B, Rayon C. , et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33 (12) 3290-3295
    CrossrefPubMedGoogle Scholar
  • 299 Tintelnot K, Just-Nübling G, Horré R. , et al. A review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol 2009; 47 (04) 351-358
    CrossrefPubMedGoogle Scholar
  • 300 Husain S, Muñoz P, Forrest G. , et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40 (01) 89-99
    CrossrefPubMedGoogle Scholar
  • 301 Kusne S, Ariyanayagam-Baksh S, Strollo DC, Abernethy J. Invasive Scedosporium apiospermum infection in a heart transplant recipient presenting with multiple skin nodules and a pulmonary consolidation. Transpl Infect Dis 2000; 2 (04) 194-196
    CrossrefPubMedGoogle Scholar
  • 302 Clement ME, Maziarz EK, Schroder JN, Patel CB, Perfect JR. Scedosporium apiospermum infection of the “native” valve: fungal endocarditis in an orthotopic heart transplant recipient. Med Mycol Case Rep 2015; 9: 34-36
    PubMedGoogle Scholar
  • 303 Hirschi S, Letscher-Bru V, Pottecher J. , et al. Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient. J Clin Microbiol 2012; 50 (12) 4168-4170
    CrossrefPubMedGoogle Scholar
  • 304 Tamm M, Malouf M, Glanville A. Pulmonary Scedosporium infection following lung transplantation. Transpl Infect Dis 2001; 3 (04) 189-194
    CrossrefPubMedGoogle Scholar
  • 305 Morio F, Horeau-Langlard D, Gay-Andrieu F. , et al. Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. J Clin Microbiol 2010; 48 (05) 1978-1982
    CrossrefPubMedGoogle Scholar
  • 306 Raj R, Frost AE. Scedosporium apiospermum fungemia in a lung transplant recipient. Chest 2002; 121 (05) 1714-1716
    CrossrefPubMedGoogle Scholar
  • 307 Rabodonirina M, Paulus S, Thevenet F. , et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994; 19 (01) 138-142
    CrossrefPubMedGoogle Scholar
  • 308 Balandin B, Aguilar M, Sánchez I. , et al. Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: An unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unit. Med Mycol Case Rep 2016; 11: 53-56
    CrossrefPubMedGoogle Scholar
  • 309 Musk M, Chambers D, Chin W, Murray R, Gabbay E. Successful treatment of disseminated Scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant 2006; 25 (10) 1268-1272
    CrossrefPubMedGoogle Scholar
  • 310 Denton EJ, Smibert O, Gooi J. , et al. Invasive Scedosporium sternal osteomyelitis following lung transplant: cured. Med Mycol Case Rep 2016; 12: 14-16
    CrossrefPubMedGoogle Scholar
  • 311 Lackner M, de Hoog GS, Verweij PE. , et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother 2012; 56 (05) 2635-2642
    CrossrefPubMedGoogle Scholar
  • 312 Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE. ; EUROFUNG Network. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46 (01) 62-68
    CrossrefPubMedGoogle Scholar
  • 313 Halliday CL, Chen SC, Kidd SE. , et al. Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. Int J Antimicrob Agents 2016; 48 (04) 453-458
    CrossrefPubMedGoogle Scholar
  • 314 Tortorano AM, Richardson M, Roilides E. , et al; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 2014; 20 (Suppl. 03) 27-46
    PubMedGoogle Scholar
  • 315 Lackner M, Fernández-Silva F, Guarro J, Lass-Flörl C. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii . J Antimicrob Chemother 2014; 69 (11) 3027-3032
    CrossrefPubMedGoogle Scholar
  • 316 Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47 (01) 106-117
    CrossrefPubMedGoogle Scholar
  • 317 Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003; 22 (02) 111-113
    CrossrefPubMedGoogle Scholar
  • 318 Gosbell IB, Toumasatos V, Yong J, Kuo RS, Ellis DH, Perrie RC. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 2003; 46 (5-6): 233-236
    CrossrefPubMedGoogle Scholar
  • 319 Biswas C, Sorrell TC, Djordjevic JT, Zuo X, Jolliffe KA, Chen SC. In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. J Antimicrob Chemother 2013; 68 (12) 2842-2846
    CrossrefPubMedGoogle Scholar
  • 320 Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med 2015; 36 (05) 706-714
    Article in Thieme ConnectPubMedGoogle Scholar
  • 321 Dóczi I, Gyetvai T, Kredics L, Nagy E. Involvement of Fusarium spp. in fungal keratitis. Clin Microbiol Infect 2004; 10 (09) 773-776
    CrossrefPubMedGoogle Scholar
  • 322 Godoy P, Nunes E, Silva V, Tomimori-Yamashita J, Zaror L, Fischman O. Onychomycosis caused by Fusarium solani and Fusarium oxysporum in São Paulo, Brazil. Mycopathologia 2004; 157 (03) 287-290
    CrossrefPubMedGoogle Scholar
  • 323 Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20 (04) 695-704
    CrossrefPubMedGoogle Scholar
  • 324 Nucci M, Marr KA, Queiroz-Telles F. , et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38 (09) 1237-1242
    CrossrefPubMedGoogle Scholar
  • 325 Garnica M, da Cunha MO, Portugal R, Maiolino A, Colombo AL, Nucci M. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. Clin Infect Dis 2015; 60 (06) 875-880
    CrossrefPubMedGoogle Scholar
  • 326 Herbrecht R, Kessler R, Kravanja C, Meyer MH, Waller J, Letscher-Bru V. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J Heart Lung Transplant 2004; 23 (12) 1451-1454
    CrossrefPubMedGoogle Scholar
  • 327 Terasaki JM, Shah SK, Schnadig VJ, Valentine VG. Airway complication contributing to disseminated fusariosis after lung transplantation. Transpl Infect Dis 2014; 16 (04) 621-624
    CrossrefPubMedGoogle Scholar
  • 328 Arney KL, Tiernan R, Judson MA. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest 1997; 112 (04) 1128-1130
    CrossrefPubMedGoogle Scholar
  • 329 Halpern M, Balbi E, Carius L. , et al. Cellulitis and nodular skin lesions due to Fusarium spp. in liver transplant: case report. Transplant Proc 2010; 42 (02) 599-600
    CrossrefPubMedGoogle Scholar
  • 330 Cocchi S, Codeluppi M, Venturelli C. , et al. Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole. Diagn Microbiol Infect Dis 2011; 71 (04) 438-441
    CrossrefPubMedGoogle Scholar
  • 331 Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) 2011; 90 (01) 69-80
    CrossrefPubMedGoogle Scholar
  • 332 Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009. J Infect 2010; 60 (05) 331-337
    CrossrefPubMedGoogle Scholar
  • 333 Nucci M, Anaissie EJ, Queiroz-Telles F. , et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98 (02) 315-319
    CrossrefPubMedGoogle Scholar
  • 334 Sassi C, Stanzani M, Lewis RE. , et al. Radiologic findings of Fusarium pneumonia in neutropenic patients. Mycoses 2017; 60 (02) 73-78
    CrossrefPubMedGoogle Scholar
  • 335 Nucci M, Marr KA, Vehreschild MJ. , et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect 2014; 20 (06) 580-585
    CrossrefPubMedGoogle Scholar
  • 336 Müller C, Schumacher U, Gregor M, Lamprecht G. How immunocompromised are short bowel patients receiving home parenteral nutrition? Apropos a case of disseminated Fusarium oxysporum sepsis. JPEN J Parenter Enteral Nutr 2009; 33 (06) 717-720
    CrossrefPubMedGoogle Scholar
  • 337 Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol 2008; 190 (06) 1605-1609
    CrossrefPubMedGoogle Scholar
  • 338 Nucci M, Garnica M, Gloria AB. , et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19 (08) 745-751
    CrossrefPubMedGoogle Scholar
  • 339 Guinvarc'h A, Guilbert L, Marmorat-Khuong A. , et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 1998; 41 (1–2): 59-61
    CrossrefPubMedGoogle Scholar
  • 340 Proença-Pina J, Ssi Yan Kai I, Bourcier T, Fabre M, Offret H, Labetoulle M. Fusarium keratitis and endophthalmitis associated with lens contact wear. Int Ophthalmol 2010; 30 (01) 103-107
    CrossrefPubMedGoogle Scholar
  • 341 Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10 (Suppl. 01) 67-75
    CrossrefPubMedGoogle Scholar
  • 342 Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35 (08) 909-920
    CrossrefPubMedGoogle Scholar
  • 343 Dananché C, Cassier P, Sautour M. , et al. Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency. Mycopathologia 2015; 179 (1-2): 135-140
    CrossrefPubMedGoogle Scholar
  • 344 Gaur S, Rajgopal A, Ashbee R. A successfully treated case of peritonitis due to Fusarium dimerum . J Infect 2010; 61 (01) 86-88
    CrossrefPubMedGoogle Scholar
  • 345 Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum . Am J Respir Crit Care Med 1995; 152 (4 Pt 1): 1379-1381
    CrossrefPubMedGoogle Scholar
  • 346 Rojas-Tula DG, Gómez-Fernández M, García-López JJ. , et al. Endobronchial cryotherapy for a mycetoma. J Bronchology Interv Pulmonol 2013; 20 (04) 330-332
    CrossrefPubMedGoogle Scholar
  • 347 Georgiadou SP, Velegraki A, Arabatzis M. , et al. Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. J Hosp Infect 2014; 86 (04) 267-271
    CrossrefPubMedGoogle Scholar
  • 348 Rajmane VS, Rajmane ST, Patil VC, Patil AB, Mohite ST. Maxillary rhinosinusitis due to Fusarium species leading to cavernous sinus thrombosis. J Mycol Med 2013; 23 (01) 53-56
    CrossrefPubMedGoogle Scholar
  • 349 Macêdo DP, Neves RP, Fontan J, Souza-Motta CM, Lima D. A case of invasive rhinosinusitis by Fusarium verticillioides (Saccardo) Nirenberg in an apparently immunocompetent patient. Med Mycol 2008; 46 (05) 499-503
    CrossrefPubMedGoogle Scholar
  • 350 Sierra-Hoffman M, Paltiyevich-Gibson S, Carpenter JL, Hurley DL. Fusarium osteomyelitis: case report and review of the literature. Scand J Infect Dis 2005; 37 (03) 237-240
    CrossrefPubMedGoogle Scholar
  • 351 Bader M, Jafri AK, Krueger T, Kumar V. Fusarium osteomyelitis of the foot in a patient with diabetes mellitus. Scand J Infect Dis 2003; 35 (11-12): 895-896
    CrossrefPubMedGoogle Scholar
  • 352 Terada M, Fujita J, Watanabe S. , et al. Olecranon bursa with Fusarium solani infection in an otherwise healthy patient. Mycoses 2011; 54 (06) e853-e855
    CrossrefPubMedGoogle Scholar
  • 353 Glasgow BJ, Engstrom Jr RE, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1996; 114 (07) 873-877
    CrossrefPubMedGoogle Scholar
  • 354 Busemann C, Krüger W, Schwesinger G. , et al. Myocardial and aortal involvement in a case of disseminated infection with Fusarium solani after allogeneic stem cell transplantation: report of a case. Mycoses 2009; 52 (04) 372-376
    CrossrefPubMedGoogle Scholar
  • 355 Nunes MdoC, Barbosa FB, Gomes GH, Bráulio R, Nicoliello MF, Ferrari TC. Fatal right-sided endocarditis caused by Fusarium in an immunocompromised patient: a case report. Mycoses 2011; 54 (05) 460-462
    CrossrefPubMedGoogle Scholar
  • 356 Inano S, Kimura M, Iida J, Arima N. Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review. J Infect Chemother 2013; 19 (06) 1173-1180
    CrossrefPubMedGoogle Scholar
  • 357 Madariaga MG, Kohl S. Disseminated fusariosis presenting with pulmonary nodules following a line infection. Braz J Infect Dis 2006; 10 (06) 419
    PubMedGoogle Scholar
  • 358 Gu Z, Buelow DR, Petraitiene R, Petraitis V, Walsh TJ, Hayden RT. Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction. Arch Pathol Lab Med 2014; 138 (11) 1474-1480
    CrossrefPubMedGoogle Scholar
  • 359 Wu CH, Lu PL, Hsiao HH. , et al. Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis. Ann Hematol 2014; 93 (06) 1079-1081
    CrossrefPubMedGoogle Scholar
  • 360 Bose P, Parekh HD, Holter JL, Greenfield RA. Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis. J Clin Microbiol 2011; 49 (04) 1674-1675
    CrossrefPubMedGoogle Scholar
  • 361 Kim MS, Lee HM, Sung HS. , et al. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy. Int J Dermatol 2012; 51 (05) 621-623
    CrossrefPubMedGoogle Scholar
  • 362 Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2016; 30 (01) 179-206
    CrossrefPubMedGoogle Scholar
  • 363 Parkes-Ratanshi R, Wakeham K, Levin J. , et al; Cryptococcal Trial Team. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis 2011; 11 (12) 933-941
    CrossrefPubMedGoogle Scholar
  • 364 Boulware DR, Meya DB, Muzoora C. , et al; COAT Trial Team. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 2014; 370 (26) 2487-2498
    CrossrefPubMedGoogle Scholar
  • 365 Zonios DI, Falloon J, Huang CY, Chaitt D, Bennett JE. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore) 2007; 86 (02) 78-92
    CrossrefPubMedGoogle Scholar
  • 366 Gonzalez-Duarte A, Saniger-Alba MdelM, Higuera-Calleja J. Cryptococcal meningitis in HIV-negative patients with systemic connective tissue diseases. Neurol Res 2015; 37 (04) 283-287
    CrossrefPubMedGoogle Scholar
  • 367 Singh N, Alexander BD, Lortholary O. , et al. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008; 46 (02) e12-e18
    PubMedGoogle Scholar
  • 368 Sun HY, Wagener MM, Singh N. Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis 2009; 48 (11) 1566-1576
    CrossrefPubMedGoogle Scholar
  • 369 Sun HY, Alexander BD, Lortholary O. , et al; Cryptococcal Collaborative Transplant Study Group. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis 2010; 51 (09) 1062-1069
    CrossrefPubMedGoogle Scholar
  • 370 Santos T, Aguiar B, Santos L. , et al. Invasive fungal infections after kidney transplantation: a single-center experience. Transplant Proc 2015; 47 (04) 971-975
    CrossrefPubMedGoogle Scholar
  • 371 Chang CC, Sorrell TC, Chen SC. Pulmonary cryptococcosis. Semin Respir Crit Care Med 2015; 36 (05) 681-691
    Article in Thieme ConnectPubMedGoogle Scholar
  • 372 Chen SC, Slavin MA, Heath CH. , et al; Australia and New Zealand Mycoses Interest Group (ANZMIG)-Cryptococcus Study. Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 2012; 55 (06) 789-798
    CrossrefPubMedGoogle Scholar
  • 373 Baddley JW, Schain DC, Gupte AA. , et al. Transmission of Cryptococcus neoformans by organ transplantation. Clin Infect Dis 2011; 52 (04) e94-e98
    CrossrefPubMedGoogle Scholar
  • 374 Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ. ; American Society of Transplantation, Infectious Diseases Community of Practice, Donor-Derived Fungal Infection Working Group. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice. Am J Transplant 2012; 12 (09) 2414-2428
    CrossrefPubMedGoogle Scholar
  • 375 Chang CM, Tsai CC, Tseng CE. , et al. Donor-derived Cryptococcus infection in liver transplant: case report and literature review. Exp Clin Transplant 2014; 12 (01) 74-77
    CrossrefPubMedGoogle Scholar
  • 376 Chen SC, Korman TM, Slavin MA. , et al; Australia and New Zealand Mycoses Interest Group (ANZMIG) Cryptococcus Study. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii . Clin Infect Dis 2013; 57 (04) 543-551
    CrossrefPubMedGoogle Scholar
  • 377 Chen SC, Meyer W, Sorrell TC. Cryptococcus gattii infections. Clin Microbiol Rev 2014; 27 (04) 980-1024
    CrossrefPubMedGoogle Scholar
  • 378 Tseng HK, Liu CP, Ho MW. , et al; Taiwan Infectious Diseases Study Network for Cryptococcosis. Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997–2010. PLoS One 2013; 8 (04) e61921
    CrossrefPubMedGoogle Scholar
  • 379 Phillips P, Galanis E, MacDougall L. , et al; British Columbia Cryptococcus gattii Study Group. Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia. Clin Infect Dis 2015; 60 (09) 1368-1376
    PubMedGoogle Scholar
  • 380 Harris JR, Lockhart SR, Sondermeyer G. , et al. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis 2013; 19 (10) 1620-1626
    PubMedGoogle Scholar
  • 381 Franco-Paredes C, Womack T, Bohlmeyer T. , et al. Management of Cryptococcus gattii meningoencephalitis. Lancet Infect Dis 2015; 15 (03) 348-355
    CrossrefPubMedGoogle Scholar
  • 382 Flores VG, Tovar RM, Zaldivar PG, Martinez EA. Meningitis due to Cryptococcus neoformans: treatment with posaconazole. Curr HIV Res 2012; 10 (07) 620-623
    CrossrefPubMedGoogle Scholar
  • 383 Ye F, Xie JX, Zeng QS, Chen GQ, Zhong SQ, Zhong NS. Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. Lung 2012; 190 (03) 339-346
    CrossrefPubMedGoogle Scholar
  • 384 Kishi K, Homma S, Kurosaki A, Kohno T, Motoi N, Yoshimura K. Clinical features and high-resolution CT findings of pulmonary cryptococcosis in non-AIDS patients. Respir Med 2006; 100 (05) 807-812
    CrossrefPubMedGoogle Scholar
  • 385 Zhang Y, Li N, Zhang Y. , et al. Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur Respir J 2012; 40 (05) 1191-1200
    CrossrefPubMedGoogle Scholar
  • 386 Brizendine KD, Baddley JW, Pappas PG. Pulmonary cryptococcosis. Semin Respir Crit Care Med 2011; 32 (06) 727-734
    Article in Thieme ConnectPubMedGoogle Scholar
  • 387 Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981; 94 (05) 611-616
    CrossrefPubMedGoogle Scholar
  • 388 Litvintseva AP, Carbone I, Rossouw J, Thakur R, Govender NP, Mitchell TG. Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa. PLoS One 2011; 6 (05) e19688
    CrossrefPubMedGoogle Scholar
  • 389 Hagen F, Ceresini PC, Polacheck I. , et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS One 2013; 8 (08) e71148
    CrossrefPubMedGoogle Scholar
  • 390 Chaturvedi V, Nierman WC. Cryptococcus gattii comparative genomics and transcriptomics: a NIH/NIAID White Paper. Mycopathologia 2012; 173 (5-6): 367-373
    CrossrefPubMedGoogle Scholar
  • 391 Harris J, Lockhart S, Chiller T. Cryptococcus gattii: where do we go from here?. Med Mycol 2012; 50 (02) 113-129
    CrossrefPubMedGoogle Scholar
  • 392 Andrade-Silva L, Ferreira-Paim K, Mora DJ. , et al. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Med Mycol 2013; 51 (06) 635-640
    CrossrefPubMedGoogle Scholar
  • 393 Jenney A, Pandithage K, Fisher DA, Currie BJ. Cryptococcus infection in tropical Australia. J Clin Microbiol 2004; 42 (08) 3865-3868
    CrossrefPubMedGoogle Scholar
  • 394 Hajjeh RA, Conn LA, Stephens DS. , et al; Cryptococcal Active Surveillance Group. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999; 179 (02) 449-454
    CrossrefPubMedGoogle Scholar
  • 395 Kabanda T, Siedner MJ, Klausner JD, Muzoora C, Boulware DR. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis 2014; 58 (01) 113-116
    CrossrefPubMedGoogle Scholar
  • 396 Meya DB, Okurut S, Zziwa G. , et al. Cellular immune activation in cerebrospinal fluid from Ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome. J Infect Dis 2015; 211 (10) 1597-1606
    CrossrefPubMedGoogle Scholar
  • 397 Perfect JR, Dismukes WE, Dromer F. , et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50 (03) 291-322
    CrossrefPubMedGoogle Scholar
  • 398 Day JN, Chau TTH, Wolbers M. , et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 2013; 368 (14) 1291-1302
    CrossrefPubMedGoogle Scholar
  • 399 Loyse A, Wilson D, Meintjes G. , et al. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis 2012; 54 (01) 121-128
    CrossrefPubMedGoogle Scholar
  • 400 Sionov E, Chang YC, Garraffo HM, Dolan MA, Ghannoum MA, Kwon-Chung KJ. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole. Antimicrob Agents Chemother 2012; 56 (03) 1162-1169
    CrossrefPubMedGoogle Scholar
  • 401 Smith JA, Gauthier G. New developments in blastomycosis. Semin Respir Crit Care Med 2015; 36 (05) 715-728
    Article in Thieme ConnectPubMedGoogle Scholar
  • 402 Seitz AE, Younes N, Steiner CA, Prevots DR. Incidence and trends of blastomycosis-associated hospitalizations in the United States. PLoS One 2014; 9 (08) e105466
    CrossrefPubMedGoogle Scholar
  • 403 Castillo CG, Kauffman CA, Miceli MH. Blastomycosis. Infect Dis Clin North Am 2016; 30 (01) 247-264
    CrossrefPubMedGoogle Scholar
  • 404 Baily GG, Robertson VJ, Neill P, Garrido P, Levy LF. Blastomycosis in Africa: clinical features, diagnosis, and treatment. Rev Infect Dis 1991; 13 (05) 1005-1008
    CrossrefPubMedGoogle Scholar
  • 405 Randhawa HS, Chowdhary A, Kathuria S. , et al. Blastomycosis in India: report of an imported case and current status. Med Mycol 2013; 51 (02) 185-192
    CrossrefPubMedGoogle Scholar
  • 406 Roy M, Benedict K, Deak E. , et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis 2013; 57 (05) 655-662
    CrossrefPubMedGoogle Scholar
  • 407 Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72 (05) 311-325
    CrossrefPubMedGoogle Scholar
  • 408 Jain R, Singh K, Lamzabi I, Harbhajanka A, Gattuso P, Reddy VB. Blastomycosis of bone: a clinicopathologic study. Am J Clin Pathol 2014; 142 (05) 609-616
    CrossrefPubMedGoogle Scholar
  • 409 Seo R, Oyasu R, Schaeffer A. Blastomycosis of the epididymis and prostate. Urology 1997; 50 (06) 980-982
    CrossrefPubMedGoogle Scholar
  • 410 Bariola JR, Perry P, Pappas PG. , et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010; 50 (06) 797-804
    CrossrefPubMedGoogle Scholar
  • 411 Chapman SW, Dismukes WE, Proia LA. , et al; Infectious Diseases Society of America. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46 (12) 1801-1812
    CrossrefPubMedGoogle Scholar
  • 412 Stevens DA. Coccidioidomycosis. N Engl J Med 1995; 332 (16) 1077-1082
    CrossrefPubMedGoogle Scholar
  • 413 Crum NF, Lederman ER, Stafford CM, Parrish JS, Wallace MR. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore) 2004; 83 (03) 149-175
    CrossrefPubMedGoogle Scholar
  • 414 Brown J, Benedict K, Park BJ, Thompson III GR. Coccidioidomycosis: epidemiology. Clin Epidemiol 2013; 5: 185-197
    PubMedGoogle Scholar
  • 415 Giacomazzi J, Baethgen L, Carneiro LC. , et al; Association With The LIFE Program. The burden of serious human fungal infections in Brazil. Mycoses 2016; 59 (03) 145-150
    CrossrefPubMedGoogle Scholar
  • 416 Twarog M, Thompson III GR. Coccidioidomycosis: recent updates. Semin Respir Crit Care Med 2015; 36 (05) 746-755
    Article in Thieme ConnectPubMedGoogle Scholar
  • 417 Park BJ, Sigel K, Vaz V. , et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998–2001. J Infect Dis 2005; 191 (11) 1981-1987
    CrossrefPubMedGoogle Scholar
  • 418 Rosenstein NE, Emery KW, Werner SB. , et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996. Clin Infect Dis 2001; 32 (05) 708-715
    CrossrefPubMedGoogle Scholar
  • 419 Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis 2010; 50 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 420 Ordonez ME, Farraye FA, Di Palma JA. Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy. Inflamm Bowel Dis 2013; 19 (11) 2490-2500
    CrossrefPubMedGoogle Scholar
  • 421 Mendoza N, Noel P, Blair JE. Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation. Transpl Infect Dis 2015; 17 (03) 380-388
    CrossrefPubMedGoogle Scholar
  • 422 Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001; 33 (09) 1536-1544
    CrossrefPubMedGoogle Scholar
  • 423 Vikram HR, Dosanjh A, Blair JE. Coccidioidomycosis and lung transplantation. Transplantation 2011; 92 (07) 717-721
    CrossrefPubMedGoogle Scholar
  • 424 Hartmann CA, Aye WT, Blair JE. Treatment considerations in pulmonary coccidioidomycosis. Expert Rev Respir Med 2016; 10 (10) 1079-1091
    CrossrefPubMedGoogle Scholar
  • 425 Kusne S, Taranto S, Covington S. , et al. Coccidioidomycosis transmission through organ transplantation: a report of the OPTN Ad Hoc Disease Transmission Advisory Committee. Am J Transplant 2016; 16 (12) 3562-3567
    CrossrefPubMedGoogle Scholar
  • 426 Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006; 42 (01) 103-107
    CrossrefPubMedGoogle Scholar
  • 427 Taljanovic MS, Adam RD. Musculoskeletal coccidioidomycosis. Semin Musculoskelet Radiol 2011; 15 (05) 511-526
    Article in Thieme ConnectPubMedGoogle Scholar
  • 428 Galgiani JN, Ampel NM, Blair JE. , et al; Infectious Diseases Society of America. Coccidioidomycosis. Clin Infect Dis 2005; 41 (09) 1217-1223
    CrossrefPubMedGoogle Scholar
  • 429 Galgiani JN, Catanzaro A, Cloud GA. , et al; Mycoses Study Group. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Ann Intern Med 2000; 133 (09) 676-686
    CrossrefPubMedGoogle Scholar
  • 430 Kahn A, Carey EJ, Blair JE. Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area. Liver Transpl 2015; 21 (03) 353-361
    CrossrefPubMedGoogle Scholar
  • 431 Galgiani JN, Ampel NM, Blair JE. , et al. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the treatment of coccidioidomycosis. Clin Infect Dis 2016; 63 (06) e112-e146
    CrossrefPubMedGoogle Scholar
  • 432 Hage CA, Azar MM, Bahr N, Loyd J, Wheat LJ. Histoplasmosis: up-to-date evidence-based approach to diagnosis and management. Semin Respir Crit Care Med 2015; 36 (05) 729-745
    Article in Thieme ConnectPubMedGoogle Scholar
  • 433 Kortsik C, Elmer A, Tamm I. Pleural effusion due to Histoplasma capsulatum and idiopathic CD4 lymphocytopenia. Respiration 2003; 70 (01) 118-122
    CrossrefPubMedGoogle Scholar
  • 434 Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin North Am 2016; 30 (01) 207-227
    CrossrefPubMedGoogle Scholar
  • 435 Damasceno LS, Ramos Jr AN, Alencar CH. , et al. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil. Mycoses 2014; 57 (07) 406-413
    CrossrefPubMedGoogle Scholar
  • 436 Caceres DH, Tobón AM, Cleveland AA. , et al. Clinical and laboratory profile of persons living with human immunodeficiency virus/acquired immune deficiency syndrome and histoplasmosis from a Colombian Hospital. Am J Trop Med Hyg 2016; 95 (04) 918-924
    CrossrefPubMedGoogle Scholar
  • 437 Mata-Essayag S, Colella MT, Roselló A. , et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000–2005. Medicine (Baltimore) 2008; 87 (04) 193-202
    CrossrefPubMedGoogle Scholar
  • 438 Lofgren SM, Kirsch EJ, Maro VP. , et al. Histoplasmosis among hospitalized febrile patients in northern Tanzania. Trans R Soc Trop Med Hyg 2012; 106 (08) 504-507
    CrossrefPubMedGoogle Scholar
  • 439 Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses 2013; 56 (03) 212-221
    CrossrefPubMedGoogle Scholar
  • 440 Rangwala F, Putcharoen O, Bowonwatanuwong C. , et al. Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review. Southeast Asian J Trop Med Public Health 2012; 43 (02) 436-441
    PubMedGoogle Scholar
  • 441 Peigne V, Dromer F, Elie C, Lidove O, Lortholary O. ; French Mycosis Study Group. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85 (05) 934-941
    CrossrefPubMedGoogle Scholar
  • 442 Assi M, Martin S, Wheat LJ. , et al. Histoplasmosis after solid organ transplant. Clin Infect Dis 2013; 57 (11) 1542-1549
    CrossrefPubMedGoogle Scholar
  • 443 Adenis A, Nacher M, Hanf M. , et al. Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. Am J Trop Med Hyg 2014; 90 (02) 216-223
    CrossrefPubMedGoogle Scholar
  • 444 Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7 (3-4): 109-115
    CrossrefPubMedGoogle Scholar
  • 445 Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002; 4 (03) 148-151
    CrossrefPubMedGoogle Scholar
  • 446 Hage CA, Ribes JA, Wengenack NL. , et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53 (05) 448-454
    CrossrefPubMedGoogle Scholar
  • 447 Richer SM, Smedema ML, Durkin MM. , et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis 2016; 62 (07) 896-902
    CrossrefPubMedGoogle Scholar
  • 448 Wheat LJ, Freifeld AG, Kleiman MB. , et al; Infectious Diseases Society of America. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45 (07) 807-825
    CrossrefPubMedGoogle Scholar